CD8A and neoplasm: To further demonstrate the improved specific immune response against tumor, we employed H-2Kb Trp-2 tetramers antibody to evaluate tumor-antigen specific CD8+ T cells, since Trp-2 antigen was a significantly expressed tumor-associated antigen on GL261 cells48.